Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-02-15Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation for First-episode Schizophrenia Patients [Phase 3]
This entry covers a Phase 3 clinical trial evaluating repetitive transcranial magnetic stimulation for patients with a first episode of schi…
-
CLINICAL_TRIALS research · 2012-02-14Clinical Trial Update: An Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With Schizophrenia
A completed epidemiological study update evaluating psychosocial remission and community integration in individuals with schizophrenia (and …
-
CLINICAL_TRIALS trial_result · 2012-02-10Clinical Trial Update: Effect of Genotyping for CYP450 Polymorphisms Versus Intense Clinical Monitoring on Antipsychotic Drug Treatment [NA]
A completed clinical trial evaluated whether genotyping CYP450 polymorphisms changes antipsychotic treatment strategies compared with intens…
-
CLINICAL_TRIALS trial_result · 2012-02-10Clinical Trial Update: Vitamin D Supplementation in Psychiatric Illnesses [NA]
A completed University of Massachusetts Worcester trial evaluated vitamin D supplementation in people with obesity and vitamin D deficiency …
-
CLINICAL_TRIALS trial_result · 2012-02-08Clinical Trial Update: Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia [Phase 1]
Phase 1 trial evaluating whether cariprazine affects cardiac repolarization in patients with schizophrenia has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia [Phase 2]
A Phase 2 add-on trial of PF-03463275 in outpatients with persistent negative symptoms of schizophrenia was terminated. No efficacy results …
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder [Phase 4]
Phase 4 trial evaluating the efficacy and safety of two atypical antipsychotics versus placebo in acute exacerbations of schizophrenia or sc…
-
FDA approval · 2012-01-30FDA Approved: RISPERIDONE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for a generic risperidone product from Amneal Pharmaceuticals LLC. Risperidone is an antipsychot…
-
FDA approval · 2012-01-30FDA Approved: OLANZAPINE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's generic olanzapine under an Original Application, establishing a generic version of the antipsychotic for schizophrenia …
-
FDA approval · 2012-01-30FDA Approved: RISPERIDONE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic risperidone from Aurobindo Pharma Limited, granting approval for a generic version of …
-
FDA approval · 2012-01-27FDA Approved: FANAPT — Supplemental Application (Vanda Pharmaceuticals Inc.)
FDA approves a supplemental application for Fanapt (iloperidone) submitted by Vanda Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual [Phase 4]
A Phase 4 trial comparing clozapine to treatment-as-usual for schizophrenia with comorbid cannabis use disorder; study completed with posted…
-
CLINICAL_TRIALS trial_result · 2012-01-18Clinical Trial Update: Schizophrenia, Related Troubles and Glutathione: Clinical Trial. Effects of Oral Administration of N-Acetylcysteine (NAC) on the Brain Glutathione Level and on the Symptoms of Schizophrenia [Phase 1]
A completed Phase 1 trial evaluating the effect of oral N-acetylcysteine on brain glutathione levels and schizophrenia symptom outcomes.
-
CLINICAL_TRIALS trial_result · 2012-01-13Clinical Trial Update: Treatment for First-Episode Schizophrenia [Phase 4]
Phase 4 clinical trial update for a treatment of first-episode schizophrenia, conducted by Northwell Health, and the study has been complete…
-
CLINICAL_TRIALS trial_result · 2012-01-11Clinical Trial Update: Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder [Phase 3]
Open-label Phase 3 study evaluating intramuscular olanzapine depot in patients with schizophrenia or schizoaffective disorder; results were …
-
CLINICAL_TRIALS trial_result · 2012-01-06Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation for Refractory Auditory Hallucinations in Schizophrenia [NA]
This clinical trial update examines repetitive transcranial magnetic stimulation for refractory auditory hallucinations in schizophrenia. Th…
-
CLINICAL_TRIALS trial_result · 2012-01-05Clinical Trial Update: Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting Condition [Phase 1]
This clinical trial update reports the completion of a Phase 1 bioequivalence study of olanzapine orally disintegrating tablets (5 mg) under…
-
CLINICAL_TRIALS trial_result · 2012-01-05Clinical Trial Update: Minocycline as an Adjunctive Therapy for Schizophrenia: a Randomized Controlled Study [Phase 4]
A Phase 4 randomized controlled trial is evaluating minocycline as an adjunctive therapy for schizophrenia.
-
CLINICAL_TRIALS research · 2012-01-05Clinical Trial Update: Tolerability, Safety and Efficacy of the H1-coil Deep Transcranial Magnetic Stimulation in Subjects With Negative Symptoms and Cognitive Deficits of Schizophrenia [NA]
Clinical trial update evaluating tolerability, safety, and efficacy of the H1-coil Deep Transcranial Magnetic Stimulation in individuals wit…
-
CLINICAL_TRIALS research · 2012-01-05Clinical Trial Update: Magnetoencephalographic (MEG) Correlates of Negative Symptoms in Patients Suffering From Schizophrenia and Their Influence by Add-on Treatments
This document reports an ongoing clinical trial investigating magnetoencephalographic correlates of negative symptoms in schizophrenia and h…
-
FDA approval · 2012-01-03FDA Approved: RISPERIDONE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for risperidone from Torrent Pharmaceuticals Limited.
-
FDA approval · 2012-01-03FDA Approved: RISPERIDONE — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for risperidone from Zydus Lifesciences Limited, enabling changes to an already approved generic…
-
CLINICAL_TRIALS research · 2012-01-02Clinical Trial Update: Chronic Cannabis Users: A Model for Negative Symptoms in Schizophrenia [NA]
A clinical trial update exploring chronic cannabis use as a model for negative symptoms in schizophrenia; current study status is unknown.
-
CLINICAL_TRIALS research · 2012-01-02Clinical Trial Update: Body Movement Imitation and Perspective Perception Among Psychiatric Patients [NA]
Clinical trial update on body movement imitation and perspective perception in schizophrenia and major depressive disorder; study status is …
-
CLINICAL_TRIALS research · 2011-12-29Clinical Trial Update: Evaluation of Generalization Paradigm Patterns Among Different Psychiatric Disorders
A clinical trial update evaluating generalization paradigm patterns across multiple psychiatric disorders, including major depressive disord…